Ignite Creation Date:
2024-05-05 @ 10:47 PM
Last Modification Date:
2024-10-26 @ 10:24 AM
Study NCT ID:
NCT01186744
Status:
COMPLETED
Last Update Posted:
2018-12-26
First Post:
2010-08-20
Brief Title:
A Study To Evaluate The Effects And Safety Of Treatment Treatment Withdrawal Followed By Re-Treatment With CP-690550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Sponsor:
Pfizer
Organization:
Pfizer
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Psoriasis |
Keywords:
| Name | View |
|---|---|
| retreat | View |
| OPT Retreatment | View |
| OPT | View |
| chronic | View |
| moderate | View |
| severe | View |
| treatment | View |
| safety | View |
| treatment withdrawal | View |
| retreatment | View |
| retreatment withdrawal | View |
| CP-690550 | View |
| Psoriasis Vulgaris | View |
| Plaque Psoriasis | View |
| tofacitinib | View |
| Xeljanz | View |
| nail psoriasis | View |
| Jak-inhibitor | View |
| oral treatment | View |
| Pruritus | View |
| Itch | View |
| DLQI | View |
| rebound | View |
| intermittent | View |